# Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry

> **NCT06086132** · — · RECRUITING · sponsor: **University of Bologna** · enrollment: 10000 (estimated)

## Conditions studied

- Cancer Related Cardiovascular Toxicity

## Interventions

- **COMBINATION_PRODUCT:** Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy

## Key facts

- **NCT ID:** NCT06086132
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06086132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06086132, "Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06086132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*